Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Kevin brings years of experience in the financial services industry having managed Data Operations, Change Management and Market Data Commercial/Procurement teams across Operations, Technology and directly in the business.
In his most recent role as Global Head of Market Data at HSBC, Kevin managed a multi-million-dollar budget, servicing 8 businesses to meet their needs and requirements with market data solutions. Prior to HSBC, Kevin worked for Thomson Reuters managing their Data Operations team which encompassed the Real Time Exchange Traded Instrument domain, running an operations team of 500+ staff across 60 global locations.
Kevin holds a Masters in Professional Development in Management and Business from Exeter University in the United Kingdom.
Chris Kelley joined Evaluate in 2017 and has led Evaluate's sales and account management teams as Chief Revenue Officer since 2020.
Prior to Evaluate, Chris was responsible for leading and growing the Americas business for UpToDate from $70m-$180m over his 5 year tenure at Wolters Kluwer. He has also held sales leadership roles at Grand Circle Travel, Basho Technologies, and Forrester Research.
Jon leads innovation, R&D, product and data science at Evaluate, focusing on the creation of new products and solutions, along with delivering enhancements to current ones. He led Evaluate’s journey into predictive analytics, driving research and development around machine learning models to quantify risk and return of drug development candidates.
After graduating in biochemistry from the University of Warwick, he joined Evaluate in 2004 and became responsible for maintaining Evaluate’s high quality forecast and financial coverage, along with the creation of various forecast-related offerings. In 2015, Jon co-founded Evaluate's professional services team, engaging closely with clients and leading on delivery of client projects for three years.
Michael leads Norstella’s Strategic Intelligence business unit with a focus on portfolio prioritization and evaluating the commercial aspects of a drug, disease and the market sector to assess risk, benchmark and predict future impact. His 21 years of experience have helped to shape our key products: Citeline, Datamonitor Healthcare, and Biomedtracker.
Cem joins Evaluate after 11 years at IQVIA where he most recently led the Portfolio Strategy Consulting Practice in EMEA and established and grew consulting services business in different geographies. He brings 20 years of life sciences and technology experience to Evaluate, with global management experience in four continents including the US, Europe, Middle East, and Africa.
Cem earned his Ph.D. from the University of Michigan, Ann Arbor, focusing on the applications of Artificial Intelligence to solve large-scale, complex real-word problems.
Christina Kay joined Evaluate in 2021 as VP Global Customer Success Manager. She brings over 20 years of International Commercial experience encompassing both Sales & Customer Success, having specialised in Customer Success for the last 8 years. Christina is passionate about transforming organisations to focus on Customer Centricity, exceptional Customer Experience & ensuring the Voice of the Customer is at the forefront for each decision point. Christina brings a new level of understanding to who our customers are and what matters to them.
Shashi joined Evaluate in August 2022 as VP - Technology based in Boston. Shashi brings more than 20 years of technology leadership experience leading global technology teams within financial services and news sectors. Shashi was with Thomson Reuters for 24 years and he spent the last 5 years with Reuters as Senior Director for Editorial Technology.